IL101928A0 - Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules - Google Patents
Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of moleculesInfo
- Publication number
- IL101928A0 IL101928A0 IL101928A IL10192892A IL101928A0 IL 101928 A0 IL101928 A0 IL 101928A0 IL 101928 A IL101928 A IL 101928A IL 10192892 A IL10192892 A IL 10192892A IL 101928 A0 IL101928 A0 IL 101928A0
- Authority
- IL
- Israel
- Prior art keywords
- bdnf
- treatment
- motor neuron
- molecules
- members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Water Treatment By Sorption (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72770491A | 1991-07-10 | 1991-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL101928A0 true IL101928A0 (en) | 1992-12-30 |
Family
ID=24923677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL101928A IL101928A0 (en) | 1991-07-10 | 1992-05-19 | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP0593516B1 (de) |
| JP (1) | JPH06509094A (de) |
| CN (1) | CN1065768C (de) |
| AT (1) | ATE202939T1 (de) |
| AU (2) | AU675409B2 (de) |
| CA (1) | CA2113083A1 (de) |
| DE (1) | DE69231930T2 (de) |
| DK (1) | DK0593516T3 (de) |
| ES (1) | ES2157903T3 (de) |
| FI (1) | FI940098A (de) |
| GR (1) | GR3036776T3 (de) |
| HU (1) | HUT70275A (de) |
| IE (1) | IE921602A1 (de) |
| IL (1) | IL101928A0 (de) |
| NO (1) | NO940084L (de) |
| PT (1) | PT100501A (de) |
| RU (1) | RU94016525A (de) |
| SK (1) | SK2694A3 (de) |
| WO (1) | WO1993001300A1 (de) |
| ZA (1) | ZA923639B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4535993A (en) * | 1992-06-12 | 1994-01-04 | Regeneron Pharmaceuticals, Inc. | Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
| CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
| AU5945301A (en) * | 2000-05-05 | 2001-11-20 | Res Foundation Of City Univers | Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| EP2913393B8 (de) * | 2004-11-17 | 2020-02-26 | Seneca Biopharma, Inc. | Transplantation menschlicher Nervenzellen zur Behandlung neurodegenerativer Erkrankungen |
| WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
| CA2695997C (en) * | 2007-08-10 | 2016-11-22 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human nerve growth factor |
| WO2014111525A2 (en) | 2013-01-18 | 2014-07-24 | Anaxomics Biotech, Sl | New combination therapies for treating nervous system diseases |
| US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
| WO2023164311A2 (en) * | 2022-02-28 | 2023-08-31 | Bioincept, Llc | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
| US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
| IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
| IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
-
1992
- 1992-05-19 AU AU20095/92A patent/AU675409B2/en not_active Ceased
- 1992-05-19 CA CA2113083A patent/CA2113083A1/en not_active Abandoned
- 1992-05-19 SK SK26-94A patent/SK2694A3/sk unknown
- 1992-05-19 HU HU9400063A patent/HUT70275A/hu unknown
- 1992-05-19 CN CN92105070A patent/CN1065768C/zh not_active Expired - Fee Related
- 1992-05-19 EP EP92912453A patent/EP0593516B1/de not_active Expired - Lifetime
- 1992-05-19 DK DK92912453T patent/DK0593516T3/da active
- 1992-05-19 DE DE69231930T patent/DE69231930T2/de not_active Expired - Lifetime
- 1992-05-19 PT PT100501A patent/PT100501A/pt not_active Application Discontinuation
- 1992-05-19 AT AT92912453T patent/ATE202939T1/de not_active IP Right Cessation
- 1992-05-19 WO PCT/US1992/004228 patent/WO1993001300A1/en active IP Right Grant
- 1992-05-19 IL IL101928A patent/IL101928A0/xx unknown
- 1992-05-19 ZA ZA923639A patent/ZA923639B/xx unknown
- 1992-05-19 JP JP5502202A patent/JPH06509094A/ja active Pending
- 1992-05-19 ES ES92912453T patent/ES2157903T3/es not_active Expired - Lifetime
- 1992-05-19 EP EP96111711A patent/EP0755682A1/de not_active Withdrawn
- 1992-05-19 RU RU94016525/14A patent/RU94016525A/ru unknown
- 1992-07-01 IE IE160292A patent/IE921602A1/en not_active Application Discontinuation
-
1994
- 1994-01-10 NO NO940084A patent/NO940084L/no unknown
- 1994-01-10 FI FI940098A patent/FI940098A/fi not_active Application Discontinuation
-
1996
- 1996-11-08 AU AU70676/96A patent/AU7067696A/en not_active Abandoned
-
2001
- 2001-10-03 GR GR20010401637T patent/GR3036776T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK2694A3 (en) | 1995-02-08 |
| DK0593516T3 (da) | 2001-09-17 |
| FI940098A (fi) | 1994-03-10 |
| CN1065768C (zh) | 2001-05-16 |
| EP0755682A1 (de) | 1997-01-29 |
| ZA923639B (en) | 1993-02-24 |
| AU675409B2 (en) | 1997-02-06 |
| DE69231930D1 (de) | 2001-08-16 |
| IE921602A1 (en) | 1993-01-13 |
| HU9400063D0 (en) | 1994-06-28 |
| CA2113083A1 (en) | 1993-01-21 |
| CN1071585A (zh) | 1993-05-05 |
| NO940084D0 (no) | 1994-01-10 |
| EP0593516B1 (de) | 2001-07-11 |
| WO1993001300A1 (en) | 1993-01-21 |
| RU94016525A (ru) | 1996-06-10 |
| AU7067696A (en) | 1997-01-16 |
| DE69231930T2 (de) | 2002-04-11 |
| AU2009592A (en) | 1993-02-11 |
| HUT70275A (en) | 1995-09-28 |
| FI940098A0 (fi) | 1994-01-10 |
| ATE202939T1 (de) | 2001-07-15 |
| EP0593516A1 (de) | 1994-04-27 |
| NO940084L (no) | 1994-03-08 |
| PT100501A (pt) | 1993-09-30 |
| GR3036776T3 (en) | 2002-01-31 |
| EP0593516A4 (de) | 1995-01-18 |
| JPH06509094A (ja) | 1994-10-13 |
| ES2157903T3 (es) | 2001-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI108146B (fi) | Biologisesti aktiivisten, neurotrofisten NGF/BDNF-sarjan yhdistelmäproteiinien valmistus | |
| IL101928A0 (en) | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules | |
| NO951592D0 (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
| ZA886471B (en) | Conjugates of cytokines with imunologulins | |
| AU6909091A (en) | Neurologic agents for nasal administration to the brain | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| HUT47432A (en) | Process for correcting disorders of immun-complexes of the circulation systhem and monocytes with double-line dns | |
| EP0295280A4 (de) | Verwendung von Zinn-Protoporphyrin und Zinn-Mesoporphyrin zur Herstellung eines Arzneimittels für die Behandlung von Psoriasis. | |
| AU7426487A (en) | Method of treating depression using d-fenfluramine | |
| Gordon | The relationship between language and behaviour. | |
| MD1716B2 (en) | Use of melatonin for treatment of patients dependent on benzodiazepine | |
| Aurela | A systematic storytelling therapy. | |
| DE3476736D1 (en) | Use of an antihypoxidoticum with cerebral and peripheral effect | |
| Dienstfrey | Neal Miller, the dumb autonomic nervous system, and biofeedback. | |
| ES2092449A1 (es) | Procedimientos de obtencion de crema calmante para dolores musculares, articulaciones, huesos, lumbalgia, reuma antiflamatorio y quemaduras leves. |